BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3288650)

  • 1. Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer.
    Nagamani M; Hannigan EV; Dinh TV; Stuart CA
    J Clin Endocrinol Metab; 1988 Jul; 67(1):144-8. PubMed ID: 3288650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased steroid production by the ovarian stromal tissue of postmenopausal women with endometrial cancer.
    Nagamani M; Stuart CA; Doherty MG
    J Clin Endocrinol Metab; 1992 Jan; 74(1):172-6. PubMed ID: 1727818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian steroid secretion in postmenopausal women with and without endometrial cancer.
    Nagamani M; Hannigan EV; Dillard EA; Van Dinh T
    J Clin Endocrinol Metab; 1986 Mar; 62(3):508-12. PubMed ID: 3944235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer.
    Jongen VH; Hollema H; van der Zee AG; Santema JG; Heineman MJ
    BJOG; 2003 Jul; 110(7):690-5. PubMed ID: 12842061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: a useful early measure of susceptibility to insulin resistance.
    Lemay A; Turcot L; Déchêne F; Dodin S; Forest JC
    Menopause; 2010 Mar; 17(2):321-5. PubMed ID: 19745772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
    Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH
    J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 17 beta-estradiol and estrone levels in postmenopausal women with and without endometrial cancer.
    Judd HL; Lucas WE; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):272-8. PubMed ID: 950362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.
    Spinder T; Spijkstra JJ; van den Tweel JG; Burger CW; van Kessel H; Hompes PG; Gooren LJ
    J Clin Endocrinol Metab; 1989 Jul; 69(1):151-7. PubMed ID: 2471710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian and peripheral androgen and oestrogen levels in post-menopausal women: correlations with ovarian histology.
    Lucisano A; Russo N; Acampora MG; Fabiano A; Fattibene M; Parlati E; Maniccia E; Dell'Acqua S
    Maturitas; 1986 Mar; 8(1):57-65. PubMed ID: 3702762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.
    Nestler JE; Barlascini CO; Matt DW; Steingold KA; Plymate SR; Clore JN; Blackard WG
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1027-32. PubMed ID: 2498378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of endocrine and metabolic variables in postmenopausal women with endometrial carcinoma.
    Lucas WE; Yen SS
    Am J Obstet Gynecol; 1979 May; 134(2):180-6. PubMed ID: 453245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinemia in hyperthecosis of the ovaries.
    Nagamani M; Van Dinh T; Kelver ME
    Am J Obstet Gynecol; 1986 Feb; 154(2):384-9. PubMed ID: 3511712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK; Zhang SF; Zou SE; Xia X; Xu LN
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone and 17 beta-oestradiol secretion of the human ovary. II. normal postmenopausal women, postmenopausal women with endometrial hyperplasia and postmenopausal women with adenocarcinoma of the endometrium.
    Botella-Llusiá J; Oriol-Bosch A; Sánchez-Garrido F; Tresguerres JA
    Maturitas; 1980 Jan; 2(1):7-12. PubMed ID: 7402088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased bioactive luteinizing hormone levels in postmenopausal women with endometrial cancer.
    Nagamani M; Doherty MG; Smith ER; Chandrasekhar Y
    Am J Obstet Gynecol; 1992 Dec; 167(6):1825-30. PubMed ID: 1471705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Tosi F; Negri C; Perrone F; Dorizzi R; Castello R; Bonora E; Moghetti P
    J Clin Endocrinol Metab; 2012 May; 97(5):1712-9. PubMed ID: 22419715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens and estrogens in postmenopausal insulin-treated diabetic women.
    Nyholm H; Djursing H; Hagen C; Agner T; Bennett P; Svenstrup B
    J Clin Endocrinol Metab; 1989 Nov; 69(5):946-9. PubMed ID: 2677038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.